{"pageContent": "Background: Although androgen-deprivation therapy (ADT) is the foundation of treatment for prostate cancer, the physiological impacts of ADT result in functional decline and enhanced risk of chronic disease and metabolic syndrome.", "metaData": {"source": "Medium-term outcomes of active surveillance for localised prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/23473579/"}}